Delivery Order SPE2DB22D1106-SPE2DB25FFGH4
- Not listed
- The Defense Logistics Agency awarded a $1,852.34 firm fixed-price delivery order to AmerisourceBergen Drug Corp for ENGERIX-B PEDI 10 MCG/0.5 ML syringes, a pediatric hepatitis B vaccine. This non-competitive delivery order, issued on August 8, 2025, with an ultimate completion date of August 11, 2025, represents a routine pharmaceutical procurement under the company's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The place of performance is AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $1,699.56 to AmerisourceBergen Drug Corp for ENGERIX-B PEDI 10 MCG/0.5 SYRINGE 0.5ML, a pediatric hepatitis B vaccine. The award was issued on July 30, 2025, with an ultimate completion date of July 31, 2025, and was competitively awarded without set-aside restrictions. Performance will take place at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for $1,416.30 to supply ENGERIX-B PEDI 10 MCG/0.5 SYRN 0.5ML, a pediatric hepatitis B vaccine. The contract is classified as a firm fixed price delivery order with no set-aside designation, indicating competitive award, and is scheduled for completion by July 31, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $2,124.45 to AmerisourceBergen Drug Corp for the supply of ENGERIX-B PEDI 10 MCG/0.5 ml syringes on July 23, 2025, with completion targeted for July 24, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. ENGERIX-B is a hepatitis B vaccine commonly used in pediatric immunization...
- The Defense Logistics Agency awarded a delivery order valued at $1,734.75 to AmerisourceBergen Drug Corp for ENGERIX-B 20 MCG/ML vaccine (20 micrograms per milliliter syringes). This competitively awarded, firm fixed-price delivery order was issued on July 18, 2025, with an ultimate completion date of July 21, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The contract carries no set-aside designation. This delivery order is a child contract under...
- The Defense Logistics Agency awarded a delivery order valued at $2,239.14 to AmerisourceBergen Drug Corp for ENGERIX-B 20 MCG/ML vaccine syringes. This non-competitive, firm fixed-price delivery order was executed on August 11, 2025, with an ultimate completion date of August 12, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. ENGERIX-B is a hepatitis B vaccine commonly used in military and federal healthcare settings for immunization programs across the...
- The Defense Logistics Agency awarded a delivery order valued at $1,751.90 to AmerisourceBergen Drug Corp for ENGERIX-B 20 MCG/ML vaccine syringes on July 24, 2025, with an ultimate completion date of July 25, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $1,255.50 firm fixed price delivery order to Amerisourcebergen Drug Corporation for ENGERIX-B PEDI 10 MCG/0.5 SYRN 0.5ML. The place of performance will be Amerisourcebergen's Conshohocken, Pennsylvania facility. The order is for the delivery of pediatric hepatitis B vaccine and has a period of performance from July 10-11, 2023. As the DLA supports all Department of Defense branches, this order is likely associated with the agency's medical supply chain...
- The Defense Logistics Agency awarded a $1,837.56 firm fixed-price delivery order to AmerisourceBergen Drug Corp for ENGERIX-B 20 mcg/mL vaccine syringes on August 7, 2025, with an ultimate completion date of August 8, 2025. This non-set-aside contract was performed at the contractor's corporate office in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's broader pharmaceutical supply relationship with DLA. This delivery order is issued under...
- The Defense Logistics Agency Troop Support Medical awarded a $9,925.50 firm fixed price delivery order contract to Amerisourcebergen Drug Corporation for 4561543676 ENGERIX-B PEDI 10 MCG/0.5 SYRN 0.5ML. The place of performance is Conshohocken, Pennsylvania. The contract period of performance is July 19-20, 2023. Under this delivery order issued against an unidentified indefinite-delivery/indefinite-quantity vehicle, Amerisourcebergen will provide pediatric hepatitis B vaccines to the Defense...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FFGH4Delivery Order
The Defense Logistics Agency awarded a $5,233.75 firm fixed price delivery order to AmerisourceBergen Drug Corp for ENGERIX-B PEDI 10 MCG/0.5 syringe in 0.5 milliliter units. This pediatric hepatitis B vaccine delivery order was awarded on September 2, 2025, with an ultimate completion date of September 3, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This award represents a non-competitive, non-set-aside transaction issued under an existing contract vehicle. This delivery order is issued under AmerisourceBergen Drug Corp's Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion comprehensive pharmaceutical support vehicle running through December 2026 that enables the company to supply medications, vaccines, and medical supplies to support military healthcare programs globally. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement and supplies the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through this flexible contract vehicle designed to meet diverse pharmaceutical needs across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.2k | 9/2/25 |